Manji, G. A., Labadie, B. W., Lee, S. M., Pellicciotta, I., Ge, L., Sta Ana, S., Sender, N., Ross, I., Wong, W., & Raufi, A. G. (2023). MEKiAUTO: A multicenter phase 1 study of combination therapy with the MEK inhibitor, cobimetinib, immune checkpoint blockade, atezolizumab, and the autophagy inhibitor hydroxychloroquine (HCQ) in KRAS-mutated advanced malignancies. JCO Global Oncology, 9(Supplement_1), 45–45. https://doi.org/10.1200/go.2023.9.supplement_1.45

Rillamas-Sun, E., Kwan, M. L., Iribarren, C., Cheng, R., Neugebauer, R., Rana, J. S., Nguyen-Huynh, M., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Huang, Y., Shen, H., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2023). Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Research and Treatment, 201(1), 117–126. https://doi.org/10.1007/s10549-023-06997-x

Lee, M., Eng, G., Handte-Reinecker, A., Deshpande, V. S., Yilmaz, O. H., Gala, M. K., Jeon, A., Stratulat, E., Zagani, R., Taylor, M. S., Rickelt, S., Kedrin, D., Batra, A., Hashmi, A., Nishioka, N. S., Hur, C., Goyal, L., Bazerbachi, F., & Zukerberg, L. (2023). Germline Determinants of Esophageal Adenocarcinoma. Gastroenterology, 165(5), 1276-1279.e7. https://doi.org/10.1053/j.gastro.2023.07.015

Vaitsiankova, A., Thakar, T., & Ciccia, A. (2023). Base-editing screens illuminate variant effects in human hematopoiesis. Cell Reports Methods, 3(7), 100541. https://doi.org/10.1016/j.crmeth.2023.100541

Sugiura, K., Masuike, Y., Suzuki, K., Shin, A. E., Sakai, N., Matsubara, H., Otsuka, M., Sims, P. A., Lengner, C. J., & Rustgi, A. K. (2023). LIN28B promotes cell invasion and colorectal cancer metastasis via CLDN1 and NOTCH3. JCI Insight, 8(14). https://doi.org/10.1172/jci.insight.167310

Moodley, Y., van Wyk, J., Ning, Y., Wexner, S., Gounden, C., Naidoo, V., Kader, S., Neugut, A. I., & Kiran, R. P. (2023). Self-adherence to post-colonoscopy consults in patients undergoing diagnostic colonoscopy: Findings from a cross-sectional, quantitative survey at a South African quaternary hospital. PLOS ONE, 18(7), e0288752. https://doi.org/10.1371/journal.pone.0288752

Min, J., Zhao, J., Zagelbaum, J., Lee, J., Takahashi, S., Cummings, P., Schooley, A., Dekker, J., Gottesman, M. E., Rabadan, R., & Gautier, J. (2023). Mechanisms of insertions at a DNA double-strand break. Molecular Cell, 83(14), 2434-2448.e7. https://doi.org/10.1016/j.molcel.2023.06.016

Yang, W., & Shaman, J. (2023). Development of Accurate Long-lead COVID-19 Forecast. PLOS Computational Biology, 19(7), e1011278. https://doi.org/10.1371/journal.pcbi.1011278

Kabir, M., Sun, N., Hu, X., Martin, T. C., Yi, J., Zhong, Y., Xiong, Y., Kaniskan, H. Ü., Gu, W., Parsons, R., & Jin, J. (2023). Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53. Journal of the American Chemical Society, 145(27), 14932–14944. https://doi.org/10.1021/jacs.3c04640

Ho, P., Melms, J. C., Rogava, M., Frangieh, C. J., Poźniak, J., Shah, S. B., Walsh, Z., Kyrysyuk, O., Amin, A. D., Caprio, L., Fullerton, B. T., Soni, R. K., Ager, C. R., Biermann, J., Wang, Y., Khosravi-Maharlooei, M., Zanetti, G., Mu, M., Fatima, H., … Izar, B. (2023). The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity. Cancer Cell, 41(7), 1207-1221.e12. https://doi.org/10.1016/j.ccell.2023.05.014

Mato, A. R., Woyach, J. A., Brown, J. R., Ghia, P., Patel, K., Eyre, T. A., Munir, T., Lech-Maranda, E., Lamanna, N., Tam, C. S., Shah, N. N., Coombs, C. C., Ujjani, C. S., Fakhri, B., Cheah, C. Y., Patel, M. R., Alencar, A. J., Cohen, J. B., Gerson, J. N., … Jurczak, W. (2023). Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia. New England Journal of Medicine, 389(1), 33–44. https://doi.org/10.1056/nejmoa2300696

Fernandez Garcia, E., Paudel, U., Noji, M. C., Bowman, C. E., Rustgi, A. K., Pitarresi, J. R., Wellen, K. E., Arany, Z., Weissenrieder, J. S., & Foskett, J. K. (2023). The mitochondrial Ca2+ channel MCU is critical for tumor growth by supporting cell cycle progression and proliferation. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1082213

Viragova, S., Aparicio, L., Palmerini, P., Zhao, J., Valencia Salazar, L. E., Schurer, A., Dhuri, A., Sahoo, D., Moskaluk, C. A., Rabadan, R., & Dalerba, P. (2023). Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma. JNCI: Journal of the National Cancer Institute, 115(7), 838–852. https://doi.org/10.1093/jnci/djad062

Dunbar, K. J., Karakasheva, T. A., Tang, Q., Efe, G., Lin, E. W., Harris, M., Sahu, V., Sachdeva, U. M., Hu, J., Klein-Szanto, A. J., Henick, B., Diehl, J. A., Nakagawa, H., & Rustgi, A. K. (2023). Tumor-Derived CCL5 Recruits Cancer-Associated Fibroblasts and Promotes Tumor Cell Proliferation in Esophageal Squamous Cell Carcinoma. Molecular Cancer Research, 21(7), 741–752. https://doi.org/10.1158/1541-7786.mcr-22-0872

Long, J., Soni, M., Muranski, P., Miller, M. J., Conry-Cantilena, C., & De Giorgi, V. (2023). Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipient. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1207638

Shih, J., Sarmashghi, S., Zhakula-Kostadinova, N., Zhang, S., Georgis, Y., Hoyt, S. H., Cuoco, M. S., Gao, G. F., Spurr, L. F., Berger, A. C., Ha, G., Rendo, V., Shen, H., Meyerson, M., Cherniack, A. D., Taylor, A. M., & Beroukhim, R. (2023). Cancer aneuploidies are shaped primarily by effects on tumour fitness. Nature, 619(7971), 793–800. https://doi.org/10.1038/s41586-023-06266-3

Tan, S. X., Pumpalova, Y., Rogers, A. M., Bhatt, K., Herbst, C., Ruff, P., Neugut, A. I., & Hur, C. (2023). Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa. Cancer Medicine, 12(14), 15515–15529. Portico. https://doi.org/10.1002/cam4.6199

Kinslow, C. J., Mercurio, A., Kumar, P., Rae, A. I., Siegelin, M. D., Grinband, J., Taparra, K., Upadhyayula, P. S., McKhann, G. M., Sisti, M. B., Bruce, J. N., Canoll, P. D., Iwamoto, F. M., Kachnic, L. A., Yu, J. B., Cheng, S. K., & Wang, T. J. C. (2023). Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating Chemotherapy. JAMA Oncology, 9(7), 919. https://doi.org/10.1001/jamaoncol.2023.0990

Sathe, C., Accordino, M. K., DeStephano, D., Shah, M., Wright, J. D., & Hershman, D. L. (2023). Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer. Breast Cancer Research and Treatment, 200(1), 85–92. https://doi.org/10.1007/s10549-023-06957-5

Kinslow, C. J., Yu, J. B., DeStephano, D. M., Kachnic, L. A., Cheng, S. K., Neugut, A. I., & Horowitz, D. P. (2023). Risk of Squamous Cell Carcinoma of the Breast Following Postmastectomy Implant Reconstruction in Women With Breast Cancer and Carcinoma in Situ. JAMA Surgery, 158(7), 769. https://doi.org/10.1001/jamasurg.2023.0262

Li, J., Momen‐Heravi, F., Wu, X., & He, K. (2022). Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells. Oral Diseases, 29(5), 2012–2026. Portico. https://doi.org/10.1111/odi.14220

Shadman, M., Manzoor, B. S., Sail, K., Tuncer, H. H., Allan, J. N., Ujjani, C., Emechebe, N., Kamalakar, R., Coombs, C. C., Leslie, L., Barr, P. M., Brown, J. R., Eyre, T. A., Rampotas, A., Schuh, A., Lamanna, N., Skarbnik, A., Roeker, L. E., Bannerji, R., … Mato, A. R. (2023). Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study. Clinical Lymphoma Myeloma and Leukemia, 23(7), 515–526. https://doi.org/10.1016/j.clml.2023.03.010

Schvartzman, J.-M., Forsyth, G., Walch, H., Chatila, W., Taglialatela, A., Lee, B. J., Zhu, X., Gershik, S., Cimino, F. V., Santella, A., Menghrajani, K., Ciccia, A., Koche, R., Sánchez-Vega, F., Zha, S., & Thompson, C. B. (2023). Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination. Molecular Cell, 83(13), 2347-2356.e8. https://doi.org/10.1016/j.molcel.2023.05.026

Yi, J., Li, H., Chu, B., Kon, N., Hu, X., Hu, J., Xiong, Y., Kaniskan, H. U., Jin, J., & Gu, W. (2023). Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1. Cell Death & Differentiation, 30(7), 1799–1810. https://doi.org/10.1038/s41418-023-01180-7

Odai-Afotey, A., Lederman, R. I., Ko, N. Y., Gagnon, H., Fikre, T., Gundersen, D. A., Revette, A. C., Hershman, D. L., Crew, K. D., Keating, N. L., & Freedman, R. A. (2023). Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors. Breast Cancer Research and Treatment, 200(1), 127–137. https://doi.org/10.1007/s10549-023-06960-w

Kyzer, J. L., Noman, M. A. A., Cuellar, R. A. D., Chung, S. S. W., Maitra, S., Naqvi, T., Hawkinson, J. E., Wolgemuth, D. J., & Georg, G. I. (2023). Investigation of selective retinoic acid receptor alpha antagonist ER‐50891 and related analogs for male contraception. Archiv Der Pharmazie, 356(7). Portico. https://doi.org/10.1002/ardp.202300031

Chiwambutsa, S. M., Ayeni, O., Kapungu, N., Kanji, C., Thelingwani, R., Chen, W. C., Mokone, D. H., O’Neil, D. S., Neugut, A. I., Jacobson, J. S., Ruff, P., Cubasch, H., Joffe, M., & Masimirembwa, C. (2023). Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co‐Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer. Clinical Pharmacology & Therapeutics, 114(1), 127–136. Portico. https://doi.org/10.1002/cpt.2904

Polin, M., Boone, R., Lim, F., Advincula, A. P., May, B., Hur, C., & Hur, H.-C. (2023). Hysterectomy Trends and Risk of Vaginal Cuff Dehiscence: An Update by Mode of Surgery. Journal of Minimally Invasive Gynecology, 30(7), 562–568. https://doi.org/10.1016/j.jmig.2023.03.005

Doshi, A., Shaw, M., Tonea, R., Moon, S., Minyety, R., Doshi, A., Laine, A., Guo, J., & Danino, T. (2023). Engineered bacterial swarm patterns as spatial records of environmental inputs. Nature Chemical Biology, 19(7), 878–886. https://doi.org/10.1038/s41589-023-01325-2

Chung, R., McKiernan, J., Arpaia, N., Marabelle, A., & Rouanne, M. (2023). Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity. European Journal of Cancer, 187, 58–64. https://doi.org/10.1016/j.ejca.2023.03.037

Michel, A., Ro, V., McGuinness, J. E., Mutasa, S., Terry, M. B., Tehranifar, P., May, B., Ha, R., & Crew, K. D. (2023). Breast cancer risk prediction combining a convolutional neural network-based mammographic evaluation with clinical factors. Breast Cancer Research and Treatment, 200(2), 237–245. https://doi.org/10.1007/s10549-023-06966-4

Hershman, D. L., Chen, B. E., Sathe, C., Parulekar, W. R., Lemieux, J., Ligibel, J. A., Gelmon, K. A., Whelan, T. J., & Goodwin, P. J. (2023). Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32). Breast Cancer Research and Treatment, 200(1), 93–102. https://doi.org/10.1007/s10549-023-06922-2

Acheampong, T., Rodríguez, C. B., O’Neill, S. C., Agovino, M., Argov, E. J. L., & Tehranifar, P. (2023). Scientific uncertainty and perceived mammography benefits in women screened for breast cancer. Cancer Causes & Control, 34(7), 611–619. https://doi.org/10.1007/s10552-023-01697-9

Bacon, B., Repin, M., Shuryak, I., Wu, H., Santella, R. M., Terry, M. B., Brenner, D. J., & Turner, H. C. (2023). High‐throughput measurement of double strand break global repair phenotype in peripheral blood mononuclear cells after long‐term cryopreservation. Cytometry Part A, 103(7), 575–583. Portico. https://doi.org/10.1002/cyto.a.24725

Yoh, N., Los Santos, G. D., Tazhibi, M., Englander, Z., Lignelli-Dipple, A., Wu, C.-C., & Baltuch, G. (2023). Focused Ultrasound for Ablation in Neurosurgery — Present Use and Future Directions. Applied Radiology, 14–19. https://doi.org/10.37549/ar2915

Di Meo, F., Iyer, A., Akama, K., Cheng, R., Yu, C., Cesarano, A., Kurihara, N., Tenshin, H., Aljoufi, A., Marino, S., Soni, R. K., Roda, J., Sissons, J., Vu, L. P., Guzman, M., Huang, K., Laskowski, T., Broxmeyer, H. E., Roodman, D. G., & Perna, F. (2023). A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma. Cell Reports Medicine, 4(7), 101110. https://doi.org/10.1016/j.xcrm.2023.101110

Li, S., Fu, J., Walker, C. J., Yang, J., Bhutani, D., Chakraborty, R., Mamillapalli, N., Mapara, M. Y., Landesman, Y., & Lentzsch, S. (2023). Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects. Blood Advances, 7(12), 2926–2937. https://doi.org/10.1182/bloodadvances.2021006638

DeBlasi, J. M., Falzone, A., Caldwell, S., Prieto-Farigua, N., Prigge, J. R., Schmidt, E. E., Chio, I. I. C., Karreth, F. A., & DeNicola, G. M. (2023). Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression. Cancer Research, 83(12), 1953–1967. https://doi.org/10.1158/0008-5472.can-22-3848

Allen, P. B., Lu, X., Chen, Q., O’Shea, K., Chmiel, J. S., Slonim, L. B., Sukhanova, M., Savas, H., Evens, A. M., Advani, R., Pro, B., Karmali, R., Palmer, B., Bayer, R. A., Eisner, R. M., Mou, E., Dillehay, G., Gordon, L. I., & Winter, J. N. (2023). Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma. Blood Advances, 7(12), 2670–2676. https://doi.org/10.1182/bloodadvances.2022008116

Ma, L., Liu, Y., Wang, Y., Yang, J., Lu, J., Feng, H., Ye, S., & Liu, Y. (2023). Identification of PTPN20 as an innate immunity-related gene in gastric cancer with Helicobacter pylori infection. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1212692

Lo, E. K. W., Mears, B. M., Maurer, H. C., Idrizi, A., Hansen, K. D., Thompson, E. D., Hruban, R. H., Olive, K. P., & Feinberg, A. P. (2023). Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis. Cancer Research, 83(11), 1905–1916. https://doi.org/10.1158/0008-5472.can-22-4052

Ellingson, B. M., Wen, P. Y., Chang, S. M., van den Bent, M., Vogelbaum, M. A., Li, G., Li, S., Kim, J., Youssef, G., Wick, W., Lassman, A. B., Gilbert, M. R., de Groot, J. F., Weller, M., Galanis, E., & Cloughesy, T. F. (2023). Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival. Neuro-Oncology, 25(6), 1017–1028. https://doi.org/10.1093/neuonc/noad002

Yang, E. J.-N., Boldogh, I. R., Ji, H., Pon, L., & Swayne, T. C. (2023). Imaging of mtHyPer7, a Ratiometric Biosensor for Mitochondrial Peroxide, in Living Yeast Cells. Journal of Visualized Experiments, 196. https://doi.org/10.3791/65428

Mundi, P. S., Dela Cruz, F. S., Grunn, A., Diolaiti, D., Mauguen, A., Rainey, A. R., Guillan, K., Siddiquee, A., You, D., Realubit, R., Karan, C., Ortiz, M. V., Douglass, E. F., Accordino, M., Mistretta, S., Brogan, F., Bruce, J. N., Caescu, C. I., Carvajal, R. D., … Califano, A. (2023). A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies. Cancer Discovery, 13(6), 1386–1407. https://doi.org/10.1158/2159-8290.cd-22-1020

Eichhorst, B., Lamanna, N., O’Brien, S. M., Tam, C. S., Qiu, L., Yang, K., Wu, K., Salmi, T., Barnes, G., & Brown, J. R. (2023). Zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma (R/R CLL/SLL): Impact on health‐related quality of life. Hematological Oncology, 41(S2), 463–464. Portico. https://doi.org/10.1002/hon.3164_341

Michel, A., Lee, R. T., Salehi, E., & Accordino, M. K. (2023). Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling. American Society of Clinical Oncology Educational Book, 43. https://doi.org/10.1200/edbk_390428

Botta, S., de Prisco, N., Chemiakine, A., Brandt, V., Cabaj, M., Patel, P., Doron‐Mandel, E., Treadway, C. J., Jovanovic, M., Brown, N. G., Soni, R. K., & Gennarino, V. A. (2023). Dosage sensitivity to Pumilio1 variants in the mouse brain reflects distinct molecular mechanisms. The EMBO Journal, 42(11). Portico. https://doi.org/10.15252/embj.2022112721

Beauchemin, M. P., Roth, M. E., & Parsons, S. K. (2023). Reducing Adolescent and Young Adult Cancer Outcome Disparities Through Optimized Care Delivery: A Blueprint from the Children’s Oncology Group. Journal of Adolescent and Young Adult Oncology. https://doi.org/10.1089/jayao.2022.0136

Kim, S., Carvajal, R., Kim, M., & Yang, H. W. (2023). Kinetics of RTK activation determine ERK reactivation and resistance to dual BRAF/MEK inhibition in melanoma. Cell Reports, 42(6), 112570. https://doi.org/10.1016/j.celrep.2023.112570

Tshering, L. F., Luo, F., Russ, S., Szenk, M., Rubel, D., Tutuska, K., Rail, J. G., Balázsi, G., Shen, M. M., & Talos, F. (2023). Immune mechanisms shape the clonal landscape during early progression of prostate cancer. Developmental Cell, 58(12), 1071-1086.e8. https://doi.org/10.1016/j.devcel.2023.04.010